Wire · opportunities
Eclipse Ingredients on its staged path to scale for human lactoferrin
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 September 2026 · Fusion42 review
Australian precision fermentation startup Eclipse Ingredients is preparing for a commercial launch of its human lactoferrin product next year, initially targeting cosmetics before expanding into adult nutrition and infant formula, leveraging partnerships to scale production efficiently.
This Wire brief sits within Fusion42's coverage of Foodtech.
◆ ◆ The Wire takeaway
You can enter the human lactoferrin market with lower upfront production costs by partnering for scale rather than building facilities. If you supply ingredients or distribution in nutrition or cosmetics, Eclipse’s speedy approach opens a path to big customers globally.
◆ Coverage
1 source · 27 Sep 2026
◆ Related on Wire
◆ Topics